- $2.13m
- $49.13m
- $192.35m
Brief: Zynex Receives FDA Clearance Of CM-1600 Monitor For Improved Blood And Fluid Management
Zynex rises on $10 mln share buyback plan
Brief: Zynex Announces Share Buyback Program
Brief: Zynex Says Prices Upsized $52.5 Mln Convertible Senior Notes Offering
U.S. STOCKS ON THE MOVE-Peloton, New Fortress Energy, Qualcomm
U.S. STOCKS ON THE MOVE-Paramount Global, First Horizon, Soligenix
U.S. STOCKS ON THE MOVE-Royal Caribbean Cruises, Moderna, Shopify
Zynex says CEO pulls stock sale, co to pursue notes offering; shares slide
Zynex sinks on planned CEO stock sale, convertible debt offering
Brief: Zynex Announces Proposed Secondary Public Offering Of Common Stock
Brief: Zynex Announces Proposed $50 Million Offering Of Convertible Senior Notes
Brief: Zynex Q1 revenue USD 42.2 million
Zynex Inc reports results for the quarter ended in March - Earnings Summary
Brief: Zynex Announces 2023 First Quarter Earnings
Zynex Inc expected to post earnings of 1 cent a share - Earnings Preview
Zynex rises on higher orders in Q1
Brief: Zynex Reports Preliminary First Quarter 2023 Results
Brief: Zynex Sees FY EPS Of USD 0.4-0.5
Zynex Inc reports results for the quarter ended in December - Earnings Summary